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1. ABBREVIATIONS 
 
AA  Arachidonic acid 
AS  Ammonium sulphate 
acac  Acetylacetonate 
Amp  Ampicillin 
Cat  Catechol 
Cmp  Chloramphenicol 
CPMG   Carr, Purcell, Meiboom and Gill 
CV  Column volumes 
DAUDA 11-[5-(Dimethylamino)-1-naphtalenesulfonylamino]-undecanoic acid 
DHBA  Dihydroxybenzoic acid 
DHBS  Dihydroxybenzoyl-serine 
DMSO  Dimethyl sulfoxide 
DNA  Deoxyribonucleic acid 
dNTP  Deoxyribonucleotide 
EDTA  Ethylene-diamine-tetra-acetic acid 
Ent  Enterobactin 
FABP  Fatty Acid Binding Protein 
FID  Free Induction Decay 
GdmCl Guanidinium chloride 
HSQC   Heteronuclear Single Quantum Coherence 
INEPT  Insensitive Nuclei Enhanced by Polarization Transfer 
IPTG  Isopropyl-β-D-thiogalactopyranosid 
Kan  Kanomycin 
KD  Dissociation constant 
kDa  Kilodalton 
  
6 
Ksp  Solubility product 
LB   Lysogeny broth 
MMP-9 Matrix Metalloproteinase-9 
NaAc  Sodium acetate 
NGAL  Neutrophil Gelatinase-Associated Lipocalin 
NMR  Nuclear Magnetic Resonance 
NOE  Nuclear Overhauser Effect 
OD600  absorbance at 600 nm (“optical density“) 
PBS  Phosphate Buffer Saline 
PCR  Polymerase Chain Reaction 
PDB  RCSB Protein Data Bank 
Pi  Phosphate 
ppm  Parts per million     
TRIS  Trishydroxymethylaminomethane 
 
Amino acids are abbreviated in one- or three-letter code. 
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2. INTRODUCTION 
 
2.1. Preview 
In this thesis, the human protein NGAL and its quail homologue Q83 were 
investigated. Basically they are secreted transport proteins, however, associated 
with a wide variety of functions. NGAL and Q83 belong to the class of siderocalins, 
a subclass of lipocalins. This class is characterized by forming a β-barrel, capable 
of inclosing mainly hydrophobic ligands. The functions of NGAL and Q83 are directly 
connected to their ligand binding properties and therefore this is the main subject 
of discussion. 
The introduction is structured as follows. First an overview of the class of lipocalins 
and siderocalins is presented. The importance of siderocalins in iron trafficking is 
outlined and in this context the most important ligand of NGAL and Q83 will be 
delineated. Then the two proteins are characterized more closely, including a 
description of the newfound secondary binding site of Q83. Subsequently the main 
methods exploited, biomolecular NMR spectroscopy and fluorescence quenching 
analysis are presented. The last paragraph of the introduction will give a brief 
overview of the work done in this thesis. 
 
2.2. Lipocalins 
Lipocalins are a class of secreted proteins that exist in a wide range of organisms, 
namely vertebrates, invertebrates, plants and gram negative bacteria. They are 
essential in various physiological processes. The two basic characteristics defining 
the class of lipocalins are already evident by the name derived from the Greek 
“lipos” (fat) and "kάlyks" (calyx). The latter term refers to the structural similarity 
among the group. All lipocalins build a calyx of an eight-stranded antiparallel β-
barrel with a highly hydrophobic interior. Enclosed in this barrel is an internal 
binding site for small hydrophobic ligands, which directly leads to their second 
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commonality, related to their function. Lipocalins are able to bind and transport 
small hydrophobic molecules such as lipids, steroids, retinoids and bilins (3). 
 
Fig. 1. Prototypical structure of a lipocalin. The collection of purple balls represents an overlay of a variety 
of different ligands. The usually narrower bottom of the calyx might be closed by a 310-helix at the N-terminus. 
The C-terminus is comprised by an α-helix, followed by a short β-strand (I). The eight anti-parallel β-strands 
that form the barrel are named A – H. Figure from Flower et al. (1). 
 
In many cases the ligands are released again after binding to specific cell surface 
receptors. So lipocalins are important in ligand trafficking, transporting various 
molecules to their site of action. As there is such a wide range of ligands involved, 
lipocalins play essential roles in diverse processes like prostaglandin synthesis, 
pheromone transport, olfaction and retinoid binding (2). Their function certainly is 
intimately connected to their ligand binding properties. However, some special 
lipocalins were found to be associated with fundamentally different biological 
processes, for instance mediation of apoptosis (22), which does not easily fit into 
the picture of simple transport proteins. Considering these seemingly unrelated 
processes it can be guessed already that lipocalins’ functions might be more 
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sophisticated than could be expected from a shallow view. In addition to ligand 
binding, some lipocalins have secondary functions, either as enzymes, e.g. 
prostaglandin D synthase (34) or by formation of protein-protein complexes, such 
as the later described NGAL-MMP-9 complex (11). Some mechanisms still remain 
unexplained to a great extent. 
The structural similarities in lipocalins occur despite the surprisingly low level of 
sequence homology across the family. Fig. 2 shows an unwound view of the 
lipocalin fold. The main structurally conserved regions are marked as boxes. Below 
are shown the amino acid sequences of some lipocalins corresponding to those 
motifs, indicating the low sequence homology. Only a few residues, marked in 
pink, occupy fixed positions with respect to the fold. 
 
 
Fig. 2. Unwound view of the lipocalin fold. The pair of dotted lines indicates hydrogen-bond connection. The 
opening of the ligand-binding site is at the top side. This end has four β-hairpin loops, in contrast to the closed 
end, that contains only three. Figure from Flower et al. (3). 
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2.3. Siderocalins 
Siderocalins are those proteins among the lipocalin family that are able to bind 
siderophores inside their calyx. Siderophores in turn are chelating molecules 
secreted by microorganisms, which are able to bind iron with extremely high 
affinity. The physiological relevance of siderocalins in this context is quite obvious. 
During infection Bacteria excrete siderophores in order to “steal” iron from the 
host. Siderocalins produced by the body in response therefore prevent iron from 
being delivered to the bacteria by capturing the iron-bound siderophores. Indeed, 
it has been shown that 24p31-deficient mice are more sensitive to bacterial 
infections (27). 
Before dealing with other processes siderocalins might be associated with, this 
process of sequestering iron will be covered in more detail. The crucial role iron 
plays in organisms makes this function a key host defense mechanism against 
bacterial infection (37). 
 
2.4. Biological Relevance of Iron 
Iron is needed in organisms in relatively large amounts. The reasons are the 
numerous enzymes and proteins containing iron as an essential cofactor.  
An adult human of 70 kg holds about 5 g of iron, which is about 1 mM for body 
volume. A bacterial cell in comparison requires an internal cell concentration of 
approximately 1 µM (39). 
Although iron is abundant in earth’s crust, its availability in aqueous environment is 
limited by the extreme insolubility of ferric hydroxide (Ksp ≈ 10-38) (38). So at pH 7 
the maximum concentration of the free aqueous ion [Fe3+] is about 10-18 M (23). 
However, even lower concentrations of free iron are toxic to the human body. So 
there have to be mechanisms in order to tightly regulate its free concentration and 
transport. This is achieved through a variety of iron-binding proteins including 
transferrin and ferritin2. The serum iron transport protein, transferrin, is known to 
maintain the ferric ion concentration at 10-24 M (15). Hence pathogenic bacteria 
                                                            
1 24p3 is a murine siderocalin and the homologue of NGAL. 
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must compete against this thermodynamic limit in order to obtain iron from the 
serum or tissue of its human host. As a limiting nutrient, iron is extremely 
important in microbial growth. That’s why bacteria have consequently evolved 
aggressive iron acquisition processes like the above stated siderophores, selective 
iron chelators, produced and secreted specifically in response to iron deficiency. In 
the following paragraph a closer look into the structure and binding mechanism of 
a well understood siderophore, enterobactin, will be provided. 
 
2.5. Enterobactin 
Enterobactin, also named enterochelin in some sources, is a derivative of a cyclic 
tri-serine lactone and tri-catechol. Catechol in turn is the ortho isomer of 
benzenediol. 
 
Fig. 3. Structure of enterobactin. The metal binding units are the catechols, that are linked to the trilactone 
by amide groups. Figure from Raymond et al. (15). 
 
Enterobactin binds FeIII with an extremely high affinity (23) to form the complex 
[FeIII(Ent)]3-. Enterobactin is a hexadentate ligand, which means it is chelated to 
the central ferric ion at six positions, namely through the oxygen atoms of the 
three catecholates. 
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Fig. 4. Ribbon structure of enterobactin in complex with iron. The metal is bound by six deprotonated 
hydroxyls. Figure from Goetz et al. (6). 
 
The Fe-free enterobactin at physiological pH exists in two forms in quite equal 
fractions. In one configuration the ortho-oxygen of the catechol is protonated and 
forms a hydrogen bond to the amide oxygen. Therefore the oxygen atoms of the 
catechol are oriented in the same direction as the amide oxygen. Upon 
deprotonation, the catecholate ring rotates around the amide bond and the ortho-
oxygen proton gets hydrogen-bonded to the amide proton (15).  
 
 
 
Fig. 5. Two existing configurations of Fe-free enterobactin. Upon protonation the catechol groups are 
rotating by 180 ° towards the outside of the molecule. Figure adapted from Abergel et al. (7). 
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The same transition coming along with deprotonation is happening upon 
coordination of FeIII. This configuration is named catecholate binding mode and is 
found at neutral pH. However at lower pH the conformation can change to the so 
called salicylate binding mode (7).  
 
 
Fig. 6. Catecholate and salicylate binding mode of enterobactin with iron. The catecholate configuration, 
shown left, can change to salicylate mode at low pH. Figure adapted from Abergel et al. (7). 
 
The salicyate form [FeIII(EntH3)]0, as will be discussed later, is predicted to be 
sterically incompatible with binding to the siderocalin, because of clashes with the 
walls of the inflexible calyx. This appears to be important for iron release in acidic 
endosomes, which will be discussed in chapter 2.6.1. 
The whole process upon binding of FeIII is nicely seen in the 3D model of 
enterobactin shown in Fig. 7. In the free molecule on the left, the catechol groups 
are locked into one rigid conformation by hydrogen bonds. Triggered by metal 
complexation, accompanied by deprotonation, the oxygens are turned towards the 
inside of the molecule by rotating the catechol rings around the amide bonds. This 
dynamic conformation seems optimal for enterobactin in order to perform its 
function as a siderophore. The “open” conformation favors rapid initial binding of 
iron and hence is suitable for prospecting the metal, whereas the conformation 
change to the “closed” geometry forms a stable complex after sequestering the 
metal (15). 
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Fig. 7. Ribbon structure of free and Fe-bound enterobactin. The structure on the left can be regarded as an 
iron prospector. The closed configuration on the right forms a compact complex. Figure from Raymond et al. 
(15). 
 
2.6. NGAL 
NGAL (neutrophil gelatinase-associated lipocalin, also called 24p3, siderocalin or 
lipocalin2) is a human siderocalin. It is a 178 amino acids protein of 21 kDa, found 
in specific granules, secretory vesicles of blood granulocytes (47). NGAL forms a 
protein-protein complex with the proenzyme form of matrix metalloproteinase-9 
(pro-MMP-9, or progelatinase B) via an intermolecular disulphide bridge (6). The 
solution structure of NGAL (20) and its crystal structure (35) reveal the typical 
eight-stranded antiparallel β-barrel with a “funnel-like” shape, made up by two 
almost orthogonal β-sheets (Fig. 8). The access to the calyx, the binding site within 
the barrel cavity, is provided by the one open end of the barrel. The opposite site, 
where the barrel gets narrower, seems to be closed by a short 310-helix. Also at this 
end of the barrel lies the free cysteine residue required for association with pro-
MMP-9. 
After activation, MMP-9 acts as a protease, degrading components of the 
extracellular matrix, such as collagens and gelatins (20). In this context NGAL has a 
regulatory influence on the proteolytic properties of MMP-9 (36). Matrix 
metalloproteinases are associated to destructive tissue remodeling, e. g. in 
invasive processes or metastasis of malignant cells (48). NGAL might play a role in 
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regulating these processes, as up-regulation of NGAL mRNA has been reported in a 
number of cancer tissues (49). 
 
Fig. 8. NMR-derived solution structure of NGAL. The left picture reveals the typical lipocalin fold. The right 
view looks into the open end of the barrel. Cysteine side chains are shown by ball-and-stick representations, 
indicating the disulphide bridge between C175 and C76 and the unpaired C87 for association with MMP-9. Figure 
from Coles et al. (20). 
 
So far two distinct physiological functions of NGAL have been discussed. On the one 
hand its role in innate immune response, sequestering bacterial siderophores, and 
then its regulatory influence on MMP-9. However, NGAL is associated with even 
more versatile processes. For instance it is supposed to function as growth factor in 
multiple cell types, acting as an iron donor for the cytoplasm (24). Iron uptake into 
endosomes might happen after binding of NGAL to a specific membrane receptor, 
such as reported for megalin (21). Another cell surface receptor that promotes 
endocytosis of NGAL, named 24p3R, has been found (9) and others are likely to 
exist. NGAL may thus be an alternative to transferrin in iron trafficking. At least it 
seems evident that there are different iron transport systems, as for instance 
deletion of the transferrin pathway does not block organogenesis (10). It might be 
that the importance of NGAL varies between diverse developmental stages. 
Especially the iron delivery pathway via the NGAL receptor 24p3R is supposed to be 
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primarily active during cell differentiation and organogenesis. NGAL was shown to 
induce formation of kidney epithelia from metanephric mesenchymal cells (41). 
NGAL mediated iron trafficking via the 24p3R seems to be an important 
complement to iron delivery by ferritin during development. The role of 24p3R in 
the adult human, where highest expression levels are found in the brain, remains 
elusive. Several findings propose importance of NGAL and its receptor in apoptosis 
by delivering or withdrawing iron from the cell (9). Self-evidently, these attributes 
are dependent on the presence or absence of a ferric siderophore bound to the 
calyx. Recent studies provide indirect evidence for the existence of mammalian 
siderophores mediating iron delivery (4, 40). Although several compounds 
synthesized by mammals, such as catechol or dihydroxybenzoic acid, revealed 
effective binding to NGAL (5), exact physiological processes remain elusive. A 
putative endogenous ligand is likely to show close structural similarities to 
enterobactin and therefore many studies were using this effectively binding 
molecule as a surrogate (7). 
 
2.6.1. Enterobactin Binding Site – The Calyx 
NGAL binds enterobactin at physiological conditions with a dissociation constant of 
0.4 nM (7). Furthermore it binds other catecholate-type molecules like parabactin, 
bacillibactin or 2,3-dihydrobenzoic acid (17, 18). The crystal structure of the 
enterobactin-bound NGAL (NGAL/[FeIII(Ent)]3-) shows that the protein forms three 
sub-pockets in the calyx where each is occupied by one catecholate ring of the 
ligand (6). However, ferric enterobactin is not highly stable and therefore a 
mixture of its decay products dihydrobenzoyl-serine and dihydrobenzoic acid 
appears in the crystal structure of the co-purified protein-ligand-complex. 
The calyx appears flatter and broader than is typical for most lipocalins. Moreover 
it is comparatively hydrophilic, containing several positively charged residues (35). 
Particularly the side chains of R81, K125 and K134 are placed between the catechol 
rings. The interacting force seems to be a mixture of electrostatic and cation-π 
interactions. Then there is a hydrogen bond formed between Y106 and the meta-
oxygen of one catecholate ring and a herringbone-type π-π-stacking interaction 
between catechols and W79 (7). 
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Fig. 9. The calyx of NGAL with bound [FeIII(Ent)]3-. The graphic to the left shows electrostatic potential by 
blue (positive) and red (negative) coloring, indicating the very positively charged binding site, unusual for 
lipocalins. Residues crucial for binding are highlighted in stick view. The aromatic rings of the ligand placed 
between the positively charged side chains are visualized in the right picture. Figure from Abergel et al. (7). 
 
The calyx seems to be quite rigid as there are no major conformational changes 
upon binding. Only side chains of W79 and R81 show significant variation in response 
to ligand binding (6). 
Iron release from NGAL occurs in acidic endosomes (10) and therefore the effects 
of pH variation on the protein might be interesting. The structure of NGAL was 
shown to be stable over the range of pH 7.4 to 2.0 (6, 35). However, as already 
stated in the part about enterobactin, in the low-pH salicylate form of this ligand 
the catechol rings are turned outwards (15). This conformation would lead to steric 
clashes with the walls of the inflexible calyx and hence does not bind. 
Fluorescence quenching analyses show that there is a dramatic decrease in affinity 
at pH 3 compared to pH 4, represented by a 300-fold increase in KD. In contrast the 
change in KD is very low between pH 7.4 and 4 (7). The pKa values of [FeIII(Ent)]3- 
are 5.2, 3.2 and 2.7, corresponding to the stepwise protonation of the meta-
oxygens of the catechol rings, resulting in the neutral salicylate complex 
[FeIII(EntH3)]0. Hence, the major decrease in affinity corresponds to the second 
protonation step of [FeIII(Ent)]3-. It should be noted, that the dramatic decrease in 
affinity is primarily caused by steric effects and not due to loss of ligand charge, 
although electrostatic forces definitely contribute to the general affinity. A similar 
effect can be observed upon addition of iron-free enterobactin, which in general 
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has a lower affinity than the ferric enterobactin but the same overall charge. At pH 
7.4 the KD for [FeIII(Ent)]3- is 0.4 nM and for [H3(Ent)]3- 3.6 nM (7). 
 
       
      
Fig. 10. NGAL titration with ferric- (left) and Fe-free- (right) enterobactin at different pH, monitored by 
fluorescence quenching analysis. Protein fluorescence at 340 nm is quenched upon ligand binding. The free 
enterobactin shows slightly less overall affinity but reveals the same drastic decrease from pH 4 to 3. Figure 
from Abergel et al. (7). 
 
Another experiment shows the increase in fluorescence upon acidification of the 
enterobactin-saturated and therefore quenched NGAL/[FeIII(Ent)]3- compex. The 
data show that significant release of the ligand starts at pH 3.5 (7). 
 
 
Fig. 11. Ligand release from 
NGAL/[FeIII(Ent)]3- upon HCl-titration 
monitored by fluorescence quenching. 
Significant release of enterobactin starts 
below pH 4. Figure from Abergel et al. 
(7). 
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NGAL releases iron in acidic endosomes where the pH is around 5. At that pH the 
catecholate form of the Fe-Ent complex is still predominant but the slightly lower 
affinity at that pH might trigger enterobactin release, whereas the ligand is 
successively removed from chemical equilibrium. However, effective release of 
iron possibly requires preceding hydrolysis of the Ent-triserine lactone, as is found 
in the NGAL/FeDHBx crystal structure. 
 
2.7. Q83 
Q83 is the quail homologue of NGAL and shows 23% identity and 64% sequence 
similarity to the human protein (27). The solution structure (14) reveals the typical 
lipocalin fold, the β-barrel formed by eight antiparallel β-strands. Also the 310 
helix, flanking the β-barrel at the N-terminus, is present. An evident structural 
difference to NGAL is the existence of a 10-residue α-helix at the back of the calyx, 
where a large Ω-loop is located in the human homologue. 
 
 
Fig. 12. Solution structure of Q83. Directly visible is the highly conserved lipocalin fold. In the loop region 
(L1) Q83 contains a short α-helix. The right view looks into the open end of the protein. Figure from Hartl et al. 
(14). 
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In line with its specific ligand enterobactin, Q83 just like NGAL features a wider 
calyx than typical for lipocalins. The conserved amino acids that form the basic 
triad of NGAL (Arg81, Lys125 and Lys134), essential for siderophore binding, have their 
analogues in Lys83, Arg102 and Arg113 in Q83. These positively charged residues, 
located at the binding site inside the calyx, can be seen as a characteristic 
structural feature for siderocalins. Indeed, Q83 binds enterobactin in a similar 
mode than NGAL and also with nearly identical dissociation constant of 0.54 nM 
(27). As the solution structure of the [GaIII(Ent)]3--bound form presents, each of the 
three catechols of enterobactin occupies one distinct binding pocket, just like 
shown for NGAL. The catechol ring that shows cation-π interaction with Lys83 seems 
to be additionally stabilized by π-π stacking with Trp62, equivalent to NGAL’s Trp79 
(27).  
So Q83 is a member of the siderocalin family, however, little is known about its 
physiological functions. Q83 was first identified after transformation with the v-
myc oncogene in quail embryo fibroblasts. In these cell lines Q83 is highly 
overexpressed, as v-myc abrogates the suppression of the Q83 gene (14). 
 
2.7.1. Fatty Acid Binding Site 
Q83 has been shown to bind unsaturated fatty acids, like arachidonic acid, with 
nanomolar dissociation constant in a binding site distinct from the calyx (46). 
 
 
Fig. 13. Structure of arachidonic acid. 
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Fatty acids are binding towards the closed end of the calyx, thus both ligands, 
siderophore and fatty acid, can bind simultaneously. This was shown by methods of 
biomolecular NMR spectroscopy, which is a valuable tool not only for solving 
solution structures, but also for characterizing interaction sites, checking protein 
fold or monitoring conformational dynamics. An introduction to biomolecular NMR 
will be given in chapter 2.7. 
 
2.7.2. Dual Binding Mode 
Fig. 14 shows the HSQC spectra of Q83 in the free form and after addition of 
[GaIII(Ent)]3- and arachidonic acid. Gallium was used as a surrogate for iron in the 
enterobactin complex, as the paramagnetic properties of iron would interfere in 
NMR experiments. The significant change in the chemical shifts of several amino 
acids upon addition of the ligands can easily be observed. The binding site for 
arachidonic acid could be located by comparing the chemical shifts of the free and 
bound form. Definitely other resonances are shifting than for enterobactin, 
indicating different localization of binding. Furthermore spectrum D shows that 
both, AA and Ent, can bind simultaneously, as it differs from the two spectra B and 
C. The same spectrum for Q83/[GaIII(Ent)]3-/AA was obtained, independent of 
which ligand was added first. Additional evidence that the two binding sites are 
distinct is given by the fact that binding of Ent leads to quenching of intrinsic 
fluorescence, whereas addition of AA does not. 
 
 2.7.3. Solution Structure of the Q83/GaEnt/AA complex 
The solution structure of the Q83/[GaIII(Ent)3-]/AA complex, which is shown in Fig. 
15, provides further insight into the dual ligand binding mode of Q83. It confirms 
that the typical lipocalin fold is conserved and that AA binds at the closed end of 
the barrel in hydrophobic environment. AA is positioned in a U-shape, the polar 
head and the methyl end pointing towards the closed end of the calyx. The 
carboxylate group might build hydrogen bonds to Thr90 and Tyr92. Also Arg6 is found 
to be located near the polar head of AA, however, its position is not well defined 
within the structural ensemble (46). 
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Fig. 14. HSQC spectra of Q83 before and after addition of either one or both ligands, [GaIII(Ent)]3- and AA. 
The spectra show that both compounds can bind simultaneously and at distinct binding sites. The same 
spectrum D is obtained regardless of which ligand is added first. Figure from Coudevylle et al. (46). 
 
 
Fig. 15. Solution structure of the Q83/[GaIII(Ent)3-]/AA complex. Enterobactin is bound in its usual way. The 
fatty acid is located towards the narrower end of the barrel and might eventually enter the protein from this 
end. Figure from Coudevylle et al. (46). 
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2.8. Objective 
There are two main issues addressed. First, does NGAL share the binding properties 
of the newfound second binding site with its quail homologue? If so, this might play 
a key role in deciphering the diverse biological functions of the protein. AA for 
instance acts as a precursor in prostaglandin synthesis and consequently is involved 
in the regulation of inflammation, one of the unexplained functions associated with 
NGAL. 
The second quest is to shed more light onto the molecular ligand binding mode of 
NGAL and Q83. This might on the one hand be helpful for defining the siderocalin 
protein family and on the other hand provide a molecular basis for explaining their 
pleiotropic functions. 
Two methods emerged to be particularly favorable for examining these questions. 
Fluoroscence quenching analysis can effectively be used to monitor binding and 
extract dissociation constants. For providing detailed insight into molecular 
processes, biomolecular NMR spectroscopy serves as a particularly valuable tool. 
 
2.9. Biomolecular NMR 
For investigation of macromolecules, 2D or 3D experiments are used. Here 
chemical shifts of two or three nuclei of different kind, usually 1H, 15N and 13C, are 
tracked in one experiment. Therefore the protein has to be labeled with the NMR 
active isotopes of nitrogen or carbon during expression. The frequencies for every 
probed nucleus are plotted on an axis. So overlapping chemical shifts can be 
distinguished by correlating them with nuclear spins of neighboring atoms. 
Elementary for these experiments is the possibility of magnetization transfer 
between vicinal nuclei, which can be described by quantum mechanics. In most 
experiments magnetization transfer via chemical bonds is employed, but there are 
also methods that employ correlation of nuclei adjacent in space. 
Of course only the evolution of one atom can be probed directly when recording 
the FID, however, in every experiment the pulse sequence is repeated many times. 
Each of these repetitions contains a different time interval during which the 
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magnetization is evolving on an element that is not directly observed. This 
evolution affects each FID recorded and therefore incrementing the time interval 
opens up a new time dimension for the other NMR active nucleus. Fourier 
transformation in this time domain gives the additional frequency dimension in the 
spectrum. 
There is a wide variety of established NMR experiments that can be used to gain 
sophisticated structural and dynamical information. 
 
2.9.1. 1H-15N HSQC 
A particularly often used experiment is the HSQC. The HSQC is a 2D experiment in 
which the correlation between 1H and 15N is exploited. The resulting spectrum is 
usually plotted with the offsets of the different 15N nuclei in the ω1 dimension and 
the offsets of the directly attached protons in the ω2 dimension. It is normally 
represented in a contour plot, where points of equal intensity are joined by lines. 
Each peak in such a spectrum corresponds to one amide group and therefore to one 
amino acid in the protein. In an unfolded protein, peaks might be poorly separated 
due to the absence of secondary structure. In a structured protein, where all amino 
acids have a defined environment, the spectral dispersion is larger. 
The peaks have to be assigned via various triple resonance experiments, probing 
the spins of 1H, 13C and 15N. 
 
HSQC Pulse Sequence 
The pulse sequence works by transferring the magnetization from the proton to the 
nitrogen by INEPT in the preparation phase. The INEPT enhances the signal for the 
15N nuclei as it transfers magnetization from the protons to the nitrogens. At a 
given magnetic field strength the equilibrium magnetization of protons is ten times 
higher than that of 15N nuclei due to their higher gyromagnetic ratio. 
The INEPT starts with a 90° x-pulse on 1H, rotating the magnetization from z to –y.  
The following magnetization transfer is done in three periods, A, B and C, 
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indicated in Fig. 16. In period A, an anti-phase state on the 1H spin is generated by 
a spin echo. The spin echo refocuses the offsets of the 1H and 15N spins but lets 
their coupling evolve for the whole time period. In period B coherence transfer is 
achieved by a 90° y-pulse on spin 1H and a simultaneous 90° x-pulse on 15N. The 
anti-phase magnetization evolves into in-phase by a second spin echo in period C, 
which now could be recorded on 15N. 
 
Fig. 16. INEPT pulse sequence. Transverse magnetization is generated on 1H and transferred to 15N. 
 
In the HSQC the time interval for the second spin echo, t1, is incremented in the 
pulse train. The magnetization of the nitrogen spin evolves for the whole time 
period t1. The t1 time corresponds to the 15N chemical shifts in the final frequency 
spectrum. 
At last the magnetization of 15N is transferred back to the 1H, where it is observed. 
 
 
Fig. 17. HSQC pulse sequence. Magnetization is transferred from 1H to 15N and back again to 1H, where it is 
observed. The time interval t1, during which magnetization is evolving on 
15N, is incremented in the pulse 
train, opening up the second frequency dimension. 
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2.9.2. Peak Assignment 
The peaks in the 1H-15N HSQC spectrum have to be assigned to the corresponding 
amino acid residues. There are several 3D NMR experiments to achieve that. Those 
described further down were used in this thesis. In the spectra of these 
experiments, the 1H and 15N chemical shifts for the different amino acids are 
visible, like in the 1H-15N HSQC, but additionally there is a frequency dimension for 
13C that reveals chemical shifts for adjacent carbons. 
 
HNCA 
In this experiment magnetization is transferred from proton through nitrogen to the 
Cα and back again to the proton. So at the peak for a given backbone amide group 
in the 1H- and 15N-dimension, the spectrum shows the Cα chemical shift of the same 
amino acid. Although the pulse sequence is optimized to transfer magnetization to 
that 13C, due to comparable coupling constants transfer also occurs to the Cα of the 
preceding residue. Therefore also the chemical shift of this nucleus is visible. The 
intensity of the peaks depends on the coupling constants between the nitrogen and 
the Cα. In α-helices the peak at the Cα chemical shift of the preceding residue is 
usually observed with lower intensity, whereas this is often not the case in β-
sheets. Complemented with other triple resonance experiments, the HNCA can be 
consulted to track the amino acid network in the protein. 
 
Fig. 18. HNCA magnetization transfer. The nuclei at which magnetization is located during the experiment 
are colored in red. The transfer is carried out via the bonds indicated by red lines. 
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HNCO 
Here magnetization is transferred from the proton via the nitrogen to the carbonyl 
carbon of the preceding residue in the amino acid sequence. This experiment 
usually gives very intense peaks and therefore enables efficient allocation of 
carbonyl carbons to the peaks belonging to the amide group of the successor amino 
acid in the 1H-15N spectrum. 
 
Fig. 19. HNCO magnetization transfer. 
 
HN(CA)CO 
In the HN(CA)CO magnetization is transferred from the proton via two nuclei, 
nitrogen and Cα, to the carbonyl carbon and back to the proton again. However, in 
the same experiment magnetization is also partly transferred to the carbonyl 
carbon of the preceding residue, via the Cα of that residue. Therefore the spectrum 
usually shows a peak for the carbonyl carbon at the 1H and 15N chemical shifts of 
the same amino acid and, at the same 1H – 15N shifts, a peak of the preceding 
carbonyl carbon. The peak intensities again depend on the coupling constants 
between the nuclei of magnetization transfer. Often it cannot be determined 
clearly which of the two carbonyl peaks corresponds to the actual or the preceding 
amino acid, respectively. However, in combination with the HNCO, the HN(CA)CO is 
an effective method to track the amino acid network, in addition to the HNCA. 
 
Fig. 20. HN(CA)CO magnetization transfer. 
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2.9.3. Protein Dynamics - CPMG 
Biomolecular NMR spectroscopy provides tools to study dynamics in a wide time 
regime. Many events relevant for protein function occur in the range of 
microseconds to milliseconds, a time scale that can be investigated by the CPMG 
experiment. 
In solution NMR the proteins are flexible to some extent and therefore not all 
molecules will be found in the same conformational state during measurement. 
States that are less populated or maintained for a shorter time range, respectively, 
are not distinctly visible in traditional experiments. If one considers a protein site 
to be in either one of two possible conformations A and B with an exchange rate, 
kex = kAB + kBA, then separate peaks are only observed if kex is much smaller than 
the chemical shift difference (Δω) between the states (slow exchange). The peak 
intensities are defined by the populations of the different conformations (pA, pB). If 
the exchange rate gets higher, the peaks are broadening and shifting towards each 
other. A kex similar to Δω refers to intermediate exchange. The timescale of fast 
exchange is characterized by kex >> Δω. 
 
 
Fig. 21. Exchange between two differently populated states in a protein. (a) Graphical representation of 
ground and excited state. The populations of the two states and the exchange rate are determined by the rate 
constants. (b) NMR spectrum for different exchange rates. Figure from Vallurupalli et al. (52). 
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Peak broadening is a direct consequence of dephasing magnetization due to 
interconversions between the conformations. In the CPMG experiment a variable 
number of 180° or П pulses, so called spin echoes, are applied during a fixed time 
interval in order to refocus the signal. The higher the frequency of applied spin 
echoes, the narrower the signal gets. This frequency, νCPMG, is plotted against the 
effective transverse relaxation rate R2,eff to give the so called dispersion curve. 
 
 
Fig. 22. (a) Schematic representation of the constant time delay in the CPMG experiment. A various number of 
refocusing pulses is applied during that time, which gives the CPMG frequency νCPMG. (b) CPMG dispersion 
curve. The decrease of R2,eff with νCPMG indicates chemical exchange. Figure from Vallurupalli et al. (52). 
 
R2,eff is calculated from the intensity (I) of the peak of interest, the duration of the 
constant time delay (T) and the intensity of a reference spectrum (I0) that lacks the 
constant time delay, R2,eff = -1/T ln(I/I0). Depending on the timescale of the 
exchange (fast, intermediate and slow) the curve can be fit with an appropriate 
function to exctract the exchange parameters, pA, pB, kex and Δω. However, there 
are two many parameters to give a unique solution. PA, pB and kex are independent 
of the field strength, whereas Δω is not. Hence, by measuring the CPMG at two 
different field strengths, ambiguity in dispersion curves can be resolved. 
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2.10. Fluorescence Quenching 
Fluorescence quenching is a common approach to monitor binding of ligands to 
proteins. This method makes use of the intrinsic fluorescence of the amino acids 
phenylalanine, tyrosine and tryptophan, whereas the latter shows most intense 
fluorescence. Usually tryptophan is rather rare in proteins. NGAL and Q83 contain 
two residues of this kind.  
 
2.10.1. Calyx Binding Site 
As a tryptophan residue is located directly at the siderophore binding site of NGAL 
and Q83, binding of enterobactin in the calyx can be tracked by fluorescence 
quenching experiments. The tryptophans of the protein in its unbound form can be 
excited at 280 nm, leading to a peak in the emission spectrum with a maximum 
around 345 nm. When [FeIII(Ent)]3- is added stepwise to the protein solution, 
whereas an emission spectrum is recorded after each step, fluorescence intensity 
decreases continually. 
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Fig. 23. Emission spectra of Q83 at different [FeIII(Ent)]3- concentrations, excited at 280 nm. Lower 
intensity curves correspond to higher ligand concentrations. When saturation is reached, further addition of 
ligand does not decrease fluorescence significantly, indicated by the close by curves at the bottom. 
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Every intensity value at a given ligand concentration is obtained by integration of 
the signal in the spectral range and not just from a single wavelength.  This 
reduces the error due to fluctuations of the spectrometer and peak drift as a result 
of ligand addition. 
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Fig. 24. The integrals of the measured intensities of each curve in Fig. 
23 plotted against [FeIII(Ent)]3- concentration. The red curve shows the fit 
with the equation shown below. 
 
The plot of fluorescence intensity versus ligand concentration can be fit with the 
following equation, assuming a single binding site model. The fit reveals the 
dissociation constant of ligand and protein. 
 
 
 
 
Imax … maximum intensity 
Isat … maximum intensity minus intensity at saturating concentration of the ligand 
[P] … protein concentration 
[L] … ligand concentration 
KD … dissociation constant 
D
2 - 4[P][L]D)([P]+[L]+K
max
[P]+[L]+K
2[P]
I = I   - Isat
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2.10.2. Fatty Acid Binding Site 
For the fatty acid binding site dissociation constants cannot be measured directly 
by fluorescence quenching, as fluorescent amino acids are not involved in binding 
here. Fluorescence quenching works efficiently only across distances of about 10 
nm, moreover, fatty acids are not effective quenchers like Ent with its aromatic 
rings. Still, ligand affinities can be investigated by an indirect method of 
fluorescence quenching. The binding site was first saturated with the fluorescent 
molecule DAUDA (11-[5-(Dimethylamino)-1-naphtalenesulfonylamino]-undecanoic 
acid or 11-(Dansylamino)undecanoic acid).  
 
 
 
 
 
 
 
 
Fig. 25. Structure of DAUDA. 
 
When DAUDA is bound to Q83, it shows intensive fluorescence with a maximum 
around 490 nm when excited at 345 nm, whereas its fluorescence intensity in 
buffer is comparatively very low in that range. Hence, binding again can be 
followed when the molecule is added to the protein solution in steps.  
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Fig. 26. Emission spectra of Q83 at different DAUDA concentrations, 
excited at 345 nm. Higher intensity curves correspond to higher DAUDA 
concentrations. 
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Fig. 27. The integrals of the measured intensities of each curve in Fig. 
26 plotted against DAUDA concentration. The red curve shows the fit 
with the equation shown below. 
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With the following equation, similar to the one used in the preceding passage, only 
this time increasing fluorescence intensity with ligand concentration is observed, 
the KD of the protein for DAUDA can be defined. 
 
 
 
Addition of AA to the DAUDA-saturated protein leads to competitive binding, 
whereas fluorescence intensity decreases again. The KD values can be constructed 
from the plot of fluorescence intensity versus the natural logarithm of the ligand 
concentration, at constant DAUDA concentrations. This graph can be fit with the 
function for a sigmoidal curve. 
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Fig. 28. The integrals of the measured intensities at different AA 
concentrations plotted against the natural logarithm of these 
concentrations. The red curve shows the sigmoidal fit. At the inflection point 
the AA concentration equals the DAUDA concentration. 
 
At the ligand concentration of the inflection point the same amount of ligand and 
DAUDA is bound. Consequently the ratio of DAUDA and the ligand at that point 
equals the ratio of their KDs. 
D
2 - 4[P][L]I = I D)([P]+[L]+Kmax
[P]+[L]+K
2[P]
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As the DAUDA concentration and its KD is known and the concentration of ligand at 
the inflection point can simply be calculated by taking the exponential of the 
logarithmic value, the KD of the ligand can be obtained. 
 
2.11. Process Overview 
The following paragraph should provide a rough overview about the work done. 
In order to delineate the siderophore binding mechanism, mutants of the basic 
triad in the Q83 calyx were designed and examined towards binding to Ent. For 
further specifications of interacting forces the ligand was applied at different 
charge by substituting the trivalent iron with the tetravalent vanadium. 
Furthermore Ent affinity was tested at increasing salt concentrations for Q83 and 
NGAL. 
Catechol and DHBA, suggested mammalian siderophores, were investigated at 
varying iron concentrations and pH values. Results were compared to those for Ent 
in order to trace possible differences in the binding mechanism. Crystallization of 
NGAL in combination with these ligands should extend structural information on 
binding of these compounds. 
For characterizing binding in the secondary binding site, various mutants of Q83 
were designed. Mutated amino acids were chosen in reference to the solution 
structure of the Q83/AA complex. By determining dissociation constants for the 
different mutants, crucial residues for binding were detected. Besides AA, several 
other fatty acids were examined towards binding to Q83. 
Considering the two binding sites, an upcoming question is to which extent these 
are coupled with each other. This was dealt with by fluorescence assays, probing 
affinities of one ligand in presence of another, bound at the other binding site. 
Moreover CPMG experiments of ligand-free and Ent-bound NGAL should elucidate 
protein dynamics and its changes upon Ent binding. 
 
KD1 / KD2 = [DAUDA] / [AA] 
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3. MATERIALS AND METHODS 
 
3.1. Buffers and Solutions 
 
Autoclaving was done at 121 °C for 15 min. 
Antibiotics were applied at following final concentrations: 
Ampicillin 100 μg/ml 
 Kanamycin 50 μg/ml 
 Chloramphenicol 50 μg/ml 
 
LB 
20 g LB-Broth stock powder 
 add dH2O to 1 l 
 autoclave 
 
LB Agar (for ≈ 20 plates) 
500 ml LB 
7.5 g agar 
 autoclave 
 cool to 55°C, 
 add antibiotics 
 pour into plates 
 store at 4°C 
 
8M Urea 
480 g Urea 
 add H2O to 1 l 
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M9 Medium 
858 ml dH2O 
100 ml of 10x M9 salts 
 autoclave 
 cool to room temp. 
1 g NH4Cl (or 15NH4Cl if needed) 
4 g glucose (or 3 g 13C-glucose if needed) 
10 ml trace elements 
100 μl 1M CaCl2 
2 ml 1M MgSO4 
 add antibiotics 
 
10x M9 Salts 
65 g Na2HPO4 
30 g KH2PO4 
5 g NaCl 
 add dH2O to 1 l 
 adjust pH to 7.4 
 autoclave 
 
Trace Elements 
EDTA 5 g/l 
FeCl3-2H2O 0.83 g/l 
ZnCl2 84 mg/l  
CuCl2-2H2O 13 mg/l  
CoCl2-2H2O 10 mg/l  
H3BO3 10 mg/l  
MnCl2-4H2O 1.6 mg/l 
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NaPi Buffer 
50 mM NaCl (2,92 g) 
10 mM NaH2PO4 (1,38 g) 
10 mM Na2HPO4 (1,78 g) 
 add dH2O to 1 l 
 adjust pH to 6.5 
 filtrate 
 degas, if used in chromatography 
 
PBS Buffer 
150 mM NaCl (8.76 g) 
5 mM NaH2PO4 (0.69 g) 
5 mM Na2HPO4 (0.89 g) 
 add dH2O to 1 l 
 adjust pH to 7.4 
 autoclave 
 
6M GdmCl 
573 g GdmCl 
 add dH2O to 1 l 
 
dNTP Mix  
2 mM dATP 
2 mM dCTP 
2 mM dGTP 
2 mM dTTP 
 in dH20 
 store at -20°C 
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3.2. Q83 
 
3.2.1. Template 
The template for the recombinant Q83 was available in a pET3d expression vector. 
The construct encodes a 157 amino acid residue protein, lacking an N-terminal 
signal sequence of the precursor protein. In vivo this 22 amino acid sequence is 
removed by post-translational cleavage. 
The calculated molecular weight of the recombinant protein is 18 079 Da and its 
calculated pI 6.97. 
The extinction coefficient was calculated to 24 535 M-1 cm-1 at 280 nm. 
 
        10         20         30         40         50         60  
MTVPDRSEIA GKWYVVALAS NTEFFLREKD KMKMAMARIS FLGEDELKVS YAVPKPNGCR  
 
        70         80         90        100        110        120  
KWETTFKKTS DDGEVYYSEE AEKKVEVLDT DYKSYAVIYA TRVKDGRTLH MMRLYSRSPE  
 
       130        140        150  
VSPAATAIFR KLAGERNYTD EMVAMLPRQE ECTVDEV  
 
 
 
Fig. 29. Amino acid sequence encoded by the Q83 template. The different residues that where mutated in 
the following are highlighted. 
 
 
3.2.2. Site-Directed Mutagensesis 
Cloning of the different mutants was done using the “QuickChange® Site-Directed 
Mutagenesis Kit” from Stratagene.  
The mutants were designed using the following primers, ordered from Sigma-
Aldrich®. 
 
R6A 
5’- GACTGTGCCGGACGCGAGCGAGATTGCAGGG -3’ 
5’- CCCTGCAATCTCGCTCGCGTCCGGCACAGTC -3’ 
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R6Q 
5’- GACTGTGCCGGACCAGAGCGAGATTGCAGGG -3’ 
5’- CCCTGCAATCTCGCTCTGGTCCGGCACAGTC -3’ 
 
Y51F 
5’- GGACGAGCTGAAGGTCTCCTTCGCAGTCCCCAAACC -3’ 
5’- GGTTTGGGGACTGCGAAGGAGACCTTCAGCTCGTCC -3’ 
 
K68A 
5’- GGGAGACAACCTTCAAGGCGACCAGTGATG -3’ 
5’- CATCACTGGTCGCCTTGAAGGTTGTCTCCC -3’ 
 
Y76F 
5’- GGTGAAGTCTTCTACTCAGAGGAAGCC -3’ 
5’- GGCTTCCTCTGAGTAGAAGACTTCACC -3’ 
 
K83A 
5’- CTCAGAGGAAGCCAAGGCAAAGGTGGAGGTGCTGGACACTGAC -3’ 
5’- GTCAGTGTCCAGCACCTCCACCTTTGCCTTGGCTTCCTCTGAG -3’ 
 
Y92F 
5’- GCTGGACACTGACTTCAAGAGCTATGC -3’ 
5’- GCATAGCTCTTGAAGTCAGTGTCCAGC -3’ 
 
 
R102A 
5’- CAGTAATCTATGCAACTGCGGTGAAGGACGGAAGGACCC -3’ 
5’- GGGTCCTTCCGTCCTTCACCGCAGTTGCATAGATTACTG -3’ 
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R113A 
5’- GGACCCTGCACATGATGGCGCTCTACAGC -3’ 
5’- GCTGTAGAGCGCCATCATGTGCAGGGTCC -3’ 
 
Y115F 
5’- GCACATGATGAGGCTCTTCAGCAGAAGCCC -3’ 
5’- GGGCTTCTGCTGAAGAGCCTCATCATGTGC -3’ 
 
R117A 
5’- GCACATGATGAGGCTCTACAGCGCAAGCCCTGAGG -3’ 
5’- CCTCAGGGCTTGCGCTGTAGAGCCTCATCATGTGC -3’ 
 
 
3.2.3. PCR 
PCR reactions were done on an “Eppendorf Mastercycler® gradient”. 
 
Reaction Mix 
10x Reaction Buffer  5 µl 
Forward Primer (100 ng/µl) 2 µl 
Reverse Primer (100 ng /µl) 2 µl 
Template (123 ng/µl)  0.5 µl 
dNTP Mix    1 µl 
dH2O     39.5 µl 
PfuTurbo® DNA Polymerase 1 µl 
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Cycling Conditions 
95°C 2 min 
95°C 30 sec 
55°C 1 min  > 20 cycles 
68°C 14 min 
4°C hold 
 
For R113A the PCR had to be repeated as the subsequent sequencing of the 
transformed and miniprepped DNA gave the plasmid without insert. The primer for 
this mutation shows a relatively low melting temperature, so 53°C was chosen for 
annealing. Furthermore the elongation step was set down to 7 minutes. 
All PCR products were digested for 5 h with the restriction enzyme DpnI in order to 
get rid of the methylated, non-mutated DNA template. 
 
 
3.2.4. Transformation 
The PCR products were transformed into Escherichia Coli DH5α cells, derived from 
Novagen, using the following protocol. 
 
• Thaw DH5α aliquot on ice (15 min) 
• Add 5 µl of mutant PCR-mix 
• Keep on ice for 5 – 30 min 
• Heat shock: 1 min at 42 °C 
• Keep on ice for 2 min 
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• Add 300 µl of LB medium (no antibiotics added) 
• Grow for 45 min in shaking incubator at 37°C and 180 rpm 
• Plate 50 – 100 µl on an LBAmp Ager Petri dish 
• Incubate over night at 37°C 
 
Ampicillin could be used to select for the cells containing the plasmid, as the 
pET3d vector contains an ampicillin resistance cassette. 
 
 
3.2.5. Miniprep 
The plasmid DNA was obtained from the transformation products using the 
following protocol. 
Small scale centrifugations were done on a tabletop centrifuge at maximum speed. 
 
• Add one colony from transformation plate to 10 ml LBAmp in a 50 ml Falcon 
tube  
• Grow over night in shaking incubator at 37°C and 180 rpm 
• Centrifuge at 3220 g for 10 min at 4°C 
• Extract DNA using the “QIAprep® Spin Miniprepr Kit” from Qiagen 
• Eluted DNA with 30 µl H2O 
 
The DNA concentration was detected with a nanodrop UV/VIS photometer. 
The plasmids were checked for the right mutation by sequencing at VBC-Biotech. 
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3.2.6. Expression 
The different plasmids with the mutations and the original plasmid were 
transformed into the expression strain Escherichia Coli BL21(DE3)pLysS derived 
from Novagen, using the following protocol. 
 
• Thaw BL21 aliquot on ice (15 min) 
• Add 0.2 µl of Miniprep product (100 – 400 ng/µl) 
• Keep on ice for 5 – 30 min 
• Heat shock: 45 sec at 42 °C 
• Keep on ice for 2 min 
• Add 300 µl of LB medium (no antibiotics added) 
• Grow for 45 min in shaking incubator at 37°C and 180 rpm 
• Plate 50 – 100 µl on an LBAmp,Cmp Ager Petri dish 
• Incubate over night at 37°C 
 
Chloramphenicol could be used in addition to ampicillin to select for the right 
colonies, as the expression strains contain the pLys plasmid with chloramphenicol 
resistance. 
 
The expression procedure is described in the following protocol. 
 
• Add one colony from transformation plate to 2 ml LBAmp,Chl in a 15 ml 
unsealed tube 
• Grow “day culture” for 7 h in a shaking incubator at 37°C and 180 rpm 
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• Add 50 µl of day culture to 20 ml of M9Amp,Chl in a 50 ml Erlenmeyer flask 
• Grow over night in shaking incubator at 37°C and 180 rpm 
• Add the 20 ml of overnight cultures to 1 l of M9Amp,Chl (15N- or 15N-13C-labeled 
if needed) in a 2 l Erlenmeyer flask (with indentations, assuring sufficient 
oxygen supply) 
• Grow in shaking incubator at 37°C and 180 rpm until OD600 reaches 0.5 (≈ 3h) 
• Induce with IPTG to a final volume of 1mM 
• Express for 5 h in the shaking incubator at 37°C and 180 rpm 
• Harvest cells at 5000 g for 15 min 
• Discarded the supernatant 
• Resuspend pellet in 15 ml PBS buffer 
• Freeze at -80°C, if cell suspension is not used directly 
 
The slightly red discolouring of the mixture produced by the Q83/Enterobactin-FeIII 
complex served as a good indicator for effective expression. 
 
 
3.2.7. Purification 
During the whole purification process the protein was kept at 4°C if possible. 
The red colour of the Q83/Enterobactin-FeIII complex, allowed localizing the 
protein visually during the whole procedure. 
Centrifugation steps for cell debris, streptomycin and ammonium sulphate 
precipitation were carried out at 35 000 g. 
Centrifugation for concentrating the protein in “Amicon Centrifugal Filter Units” 
was done at 3220 g. 
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Cell Lysis 
The cells were broken open by 15 min of sonication, pulsing 30 % of time. The cell 
debris was separated from the solution, containing the overexpressed protein, by 
centrifugation. 
Nucleic acids were precipitated by bringing the supernatant to 1 % streptomycin, 
followed by centrifugation. 
 
Ammonium Sulphate Precipitation 
Q83 is a good soluble protein which precipitates at ammonium sulphate (NH4SO4) 
concentrations higher than 60 %. The percentage refers to ammonium sulphate 
concentration in saturated water. Hence, in order to get rid of a lot of less soluble 
protein, an ammonium sulphate precipitation at 60 % was done. The amount of 
NH4SO4 in g that had to be used to reach the desired concentrations was calculated 
with the online tool of ©Encor Biotechnology Inc. 
(http://www.encorbio.com/protocols/AM-SO4.htm). Precipitate was spinned down 
and the supernatant was brought to 95 % ammonium sulphate concentration, again 
followed by centrifugation. The red pellet was resuspended in 5 ml NaPi buffer. 
 
Chromatography 
All chromatographic methods were done with “ÄktaTM Explorer” and “ÄktaTM 
Purifier” systems. 
 
Anion-Exchange 
The calculated pI of the used Q83 protein is 6.97, which means in the pH 6.5 NaPi 
buffer it is rather positively charged. In contrast DNA that is still present is 
negatively charged because of its phosphate backbone and therefore can be 
effectively separated from the protein by anion-exchange-chromatography. For 
that purpose a 6 ml “Resource Q” prepacked column was used, equilibrated with 20 
ml NaPi buffer. The sample was loaded onto the column with a flow of 1 ml/min, 
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so the pressure did not exceed 0.4 MPa. DNA was highly retarded, whereas the flow 
through containing Q83 was directly collected into a 15 ml “Amicon Centrifugal 
Filter Unit” with a 10 kDa cut-off. Q83, with its molar weight of 18 kD, was safe not 
to pass the membrane and was concentrated to less than 1 ml by centrifugation for 
about 30 min. The Resource Q column was washed in the given order with 5 CV 1 M 
NaCl, 5 CV 1 M NaOH, 5 CV 1 M NaCl, 5 CV H2O and 5 CV 20 % ethanol, in which it 
was stored. 
 
Size-Exclusion 
Size-Exclusion-Chromatography was done in order to separate Q83 from proteins 
that could not be cleared by the former methods. A “HiLoad 16/60 Superdex 75 
prep grade” prepacked column was equilibrated with 160 ml of NaPi buffer, 
whereas the bed volume is about 120 ml. The sample was loaded onto the column 
through a 1 ml loop. The pressure was kept below 0.4 MPa by a flow of 1 ml/min. 
Q83 eluted after about 70 ml and was collected in fractions of 0.8 ml into a 96 well 
plate. The Q83 containing fractions were spotted by their red discolouring and 
pipetted into a centricon. Concentrating was done as described before by 
centrifugation for about 40 min until a concentration of less than 500 µl was 
reached. The HiLoad column was washed in the given order with 0.5 CV 0.5 M 
NaOH, 3 CV H2O and 3 CV 20 % ethanol, in which it was stored. 
 
Getting Rid of the Co-Purified Ligand 
For subsequent studies on Q83, the protein had to be present in its free form, 
without enterobactin bound. Therefore the first step was to unfold the protein so it 
had no specific affinity to the ligand anymore. This was done by bringing the 
sample to 6M GdmCl and incubating it at 70°C for 30 min. Separation of the now 
unbound ligand from the protein was done with a “PD-10 Desalting column”. This is 
a prepacked, disposable column for separation of high (Mr > 5000) from low 
molecular weight substances (Mr < 1000). After equilibration with 25 ml of 6 M 
GdmCl buffer, the sample had to be applied in a volume of 2.5 ml ideally. The flow 
through was discarded and then elution was started with 3.5 ml buffer, whereas 
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the flow through was collected immediately. Compared to the protein, the 
enterobactin-iron complex was highly retarded, indicated by the remaining red 
band on the column. The manufacturer quotes a protein yield typically greater 
than 95% with less than 4% low molecular weight contamination when following the 
described procedure. After washing with 50 ml dH2O, the columns were reused 
several times. 
Proper refolding of the protein was ensured by dialysis. Therefore the 3.5 ml of 
elute from the desalting column were diluted to 30 ml with NaPi buffer and 
transferred to a dialysis bag with a 10 kDa cut-off. The solution was dialysed 3 
times against 500 ml of NaPi buffer. 
The sample was concentrated in a 15 ml “Amicon Centrifugal Filter Unit” with a 10 
kDa cut-off. After washing three times with buffer it was typically concentrated to 
a volume of about 1 ml. 
 
Verifying the Protein 
The protein concentration was determined by absorption measurement on a 
nanodrop UV/VIS photometer. The concentration was calculated from absorbance 
by Lambert Beer’s law (A = εcd). The extinction coefficient ε for Q83 at 280 nm is 
24 535 M-1 cm-1. 
The final protein yield usually was about 10 - 15 mg per liter of expression culture. 
For verifying the protein, 1H-15N HSQC spectra of the 15N-labelled samples were 
recorded and compared to the spectrum for the pure and properly folded Q83. 
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3.3. NGAL 
 
3.3.1. Template 
The recombinant NGAL construct was available in the pET38b expression vector. 
The template encodes a 176 amino acid residue protein. In contrast to the 
precursor protein, residue Cys85 is mutated to a serine, in order to prevent 
dimerisation of the protein due to disulfide bridge formation. 
The calculated molecular weight of the recombinant protein is 20 408 Da and its 
theoretical pI 9.21. 
The extinction coefficient was calculated to 27 515 M-1 cm-1 at 280 nm. 
 
        10         20         30         40         50         60  
MTSDLIPAPP LSKVPLQQNF QDNQFQGKWY VVGLAGNAIL REDKDPQKMY ATIYELKEDK  
 
        70         80         90        100        110        120  
SYNVTSVLFR KKKCDYWIRT FVPGSQPGEF TLGNIKSYPG LTSYLVRVVS TNYNQHAMVF  
 
       130        140        150        160        170  
FKKVSQNREY FKITLYGRTK ELTSELKENF IRFSKYLGLP ENHIVFPVPI DQCIDG 
 
Fig. 30. Amino acid sequence encoded by the NGAL template. The serine, replacing the wild-type-cysteine, 
is highlighted. 
 
 
3.3.2. Expression 
Expression was done similar to Q83, except for the following differences. 
The pET38b vector exhibits kanamycin resistance. Hence, kanamycin was used 
instead of ampicillin to select for positive bacteria. 
After induction with IPTG, the protein was expressed over night at 24 ° C. 
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3.3.3. Purification 
Purification was done similar to Q83, except that different concentrations for the 
ammonium sulphate precipitation were used. NGAL is less soluble and therefore 
the first step was done at 40 % NH4SO4 and the second step, at which NGAL should 
precipitate, at 65 % NH4SO4. 
 
3.4. Ligand Preparation 
An aqueous solution of metal-free enterobactin was provided from cultures of an E. 
Coli strain deregulated in enterobactin biosynthesis. The iron-bound form 
[FeIII(Ent)]3- was obtained after adding FeCl3 to the (Ent)6--solution. 
In NMR experiments, gallium, which is non-paramagnetic, was used as a substitute 
for iron, in order to avoid paramagnetic effects. The [GaIII(Ent)]3--complex was 
prepared by adding Ga(acac)3 to the metal-free solution of (Ent)6-. 
Catechol, 2,3-DHBA, arachidonic acid, lauric acid, palmitic acid, oleic acid and 
linoleic acid were received as powder from Sigma-Aldrich®. Stock solutions of 10 
mM were obtained by solubilization in DMSO. Further dilutions were done in NaPi 
buffer.   
DAUDA was also derived from Sigma-Aldrich® as powder. A 10 mM stock solution 
was produced in ethanol. Subsequent dilutions were done in NaPi buffer. 
 
3.5. NMR  
All NMR experiments were carried out in the three in-house VarianTM spectrometers 
with magnetic field strength resulting in 1H Larmor frequencies of 500, 600 and 800 
MHz. 
All samples were brought to protein concentrations between 400 µM and 2 mM in 
NaPi buffer. 
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D2O was added to a final concentration of 10 % in order to supply the sample with a 
deuterium reference. This “lock-solvent” can be used to detect changes in the 
magnetic field strength. By shim coils the field can consequently be locked to a 
constant value. 
All experiments were carried out at 25 °C.  
Data processing was done by NMRPipe and NMRDraw (42). The obtained spectra 
were analyzed with CARA and Sparky (43).  
Backbone assignment of the 1H-15N HSQC spectrum of the ligand-free NGAL and the 
NGAL/[GaIII(Ent)]3--complex was done using HNCA, HNCO and HN(CA)CO. 
The assigned HSQC spectrum of NGAL is available on the “RCSB Protein Data Bank” 
and was overlaid to the measured spectrum, so it aided as a model for the 
assignment of the enterobactin-free form of NGAL. 
CPMG data was processed with Sparky and MS Excel. The obtained matrices, 
including the peak heights for the various amino acid residues at the different 
CPMG cycles, were analyzed with MATLAB and rdnmr. 
 
3.6. Fluorescence Quenching 
All fluorescence experiments were carried out on a Perkin Elmer LS 50B 
fluorimeter. Measurements were done in NaPi buffer pH 6.5 or 7.4 at room 
temperature. 
Ligands were added to a 2 ml volume of protein solution in a quartz cuvette. 
Proper mixing was ensured by pipetting up and down with a 100 µl pipette. 
The dilution factor in the cuvette due to ligand addition was disregarded as its 
effect was evanescent compared to the error of the experiment. 
Data processing was done with MS Excel and Origin. 
Ideally around 15 spectra at regular intervals were recorded until saturation was 
reached and 10 more thereafter. 
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3.6.1. Calyx 
A 10 µM [FeIII(Ent)]3- or [VIV(Ent)]2- solution was added to 0.1 µM protein in 2 µl 
steps. At an excitation wavelength of 280 nm, the emission spectra were recorded 
between 320 and 360 nm. 
 
3.6.2. Fatty Acid Binding Site 
Q83 mutants 
The KD values for DAUDA were directly determined in every experiment. Therefore, 
first a 200 μM DAUDA solution was added to 2 ml of 2 μM protein in steps of 2 μl or 
more. The emission spectrum between 460 and 540 nm measured at an excitation 
wavelength of 345 nm. At the point where saturation was reached and emission did 
not change significantly anymore, arachidonic acid, also at 2 μl steps of 200 μM 
stock solution was added, following the same procedure as described before. 
 
Q83 wild type 
The KD of DAUDA for the wild type Q83 was determined to 100 nm. Therefore it was 
not necessary to do the DAUDA-titration at every experiment. A solution saturated 
with DAUDA, namely 5 μM for a protein concentration of 2 μM, was provided in the 
standard volume of 2 ml in the cuvette. The different ligands were again added in 
2 μl steps or more in concentrations dependent on their affinity. 
 
Q83 in the presence of [FeIII(Ent)]3- 
A more complicated method had to be applied in order to probe KDs for AA in the 
presence of bound [FeIII(Ent)]3-, because the enterobactin bound in the calyx 
quenches DAUDA fluorescence. Hence, only the binding of the fatty acid to the Ent-
free Q83 can directly be monitored. However, in the presence of both, Ent-free 
and Ent-bound Q83, conclusions can be drawn on the affinity to Ent-bound protein 
by measuring DAUDA fluorescence quenching. 
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The setups shown in Table 1 were applied in the cuvette for AA titrations. The 
[Q83free]/[Q83Ent] ratios are given in assumption that Ent is all bound to the protein. 
Titration with AA was done as usual in 2 μl steps with 250 μM and 500 μM stock 
solutions. The KD calculation is carried out and explained in the results part. 
 
 
[Q83free] / [Q83Ent] 
 
3 µM Q83 
1 µM [FeIII(Ent)]3- 
5 µM DAUDA 
 
2 µM / 1 µM 
 
4 µM Q83 
2 µM [FeIII(Ent)]3- 
5 µM DAUDA 
 
2 µM / 2 µM 
 
 
6 µM Q83 
4 µM [FeIII(Ent)]3- 
5 µM DAUDA 
 
2 µM / 4 µM 
 
 
Table 1. The left column shows the mixtures applied in the cuvette for AA titrations. The 
right column specifies the concentrations of protein in the free and Ent-bound form. 
 
 
3.7. Crystallography 
X-Ray Crystallography should give information about the orientation of ligands 
bound to the calyx of NGAL.  
Primarily a small scale crystallisation screen for NGAL was set up, trying 96 
different conditions. All crystallisation conditions were composed of sodium 
acetate, ammonium sulphate, sodium chloride and dH20 at different concentrations 
and pH values. The screen was arranged by a pipetting robot. The plate was stored 
in a hotel at 22 °C and 4 °C where it was monitored by cameras. 
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For those conditions that worked best, NGAL was crystallized by the hanging drop 
vapour diffusion method. With this method, crystals big enough for x-ray 
investigation can be obtained. Two different methods, co-crystallisation and 
soaking, were applied for producing protein crystals with 2,3-DHBA bound to the 
calyx. 
On a glass cover slip 1.3 μl of 500 μM protein were mixed with 0.5 μl solution of 
precipitant and 0.2 μl of 100 mM ligand. For crystallisation of NGAL without ligand, 
0.5 μl precipitant solution was added to 1.5 μl protein. Eight different conditions 
were selected, specified in the following table. 
 
Condition no. 1 2 3 4 5 6 7 8 
[NaAc]/[M] 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 
[AS]/[M] 1.2 1.2 1.2 1.34 1.34 1.34 1.34 1.91 
[NaCl]/[mM] 40 67 93 120 40 67 93 67 
pH 4 4 4 4 4.5 4.5 4.5 5 
 
Table 2. Crystallisation conditions for which NGAL crystals were obtained. 
 
The wells of a 48-well plate were filled with 150 μl of the accordant precipitant 
solution and sealed with a cover slip, the drop facing downwards inside the well. 
The well consequently forms a closed thermodynamic system. The drop is 
separated by air from the solution at the bottom, higher in concentration of 
precipitant. Consequently water evaporates from the drop, increasing its 
concentration towards equilibrium. So protein and salt inside the drop is 
concentrating slowly and gradually, reducing the chance of precipitation before 
crystals are formed. The plate was stored in the hotel at 22 °C. 
Obtained crystals were examined in the in-house x-ray machine to check if their 
diffraction pattern showed the expected space group and if diffraction was good 
enough to allow proper resolution. For those that diffracted well, a selection of 
eight crystals was sent to the synchrotron in Grenoble for collecting high resolution 
data. 
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4. RESULTS 
 
4.1. Enterobactin Binding Mode of Q83 and NGAL 
 
4.1.1. Cation-π Interactions - The Basic Triad 
Q83 was shown to bind [FeIII(Ent)]3- with a dissociation constant of 0.54 nM (27) in 
its classical lipocalin binding site, the calyx. As for NGAL, also for Q83 especially 
basic residues like Lysine and Arginine are supposed to be directly involved in 
siderophore binding by forming cation-π interactions or hydrogen bonds. The basic 
triad of NGAL (Arg82, Lys125 and Lys134) has its analogy in Q83’s Lys83, Arg102 and 
Arg113 (27). In order to probe the relevance of Q83’s basic residues, the mutants 
K83A, R102A and R113A were tested for their affinities to [FeIII(Ent)]3-. 
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 R113A,      KD = 7.29 ± 1.28 nM
 K83A,        KD = 1.10 ± 0.09 nM
 R102A,      KD = 1.16 ± 0.15 nM
 
Fig. 31. Fluorescence quenching of Q83 mutants upon addition of enterobactin. 
The curves are fit with the equation presented in the introduction. 
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The results show only a slight decrease in affinity for K83A and R102A. Arg113 
emerges to be the most important, with more than ten times decrease in affinity 
when mutated to alanine. However, change in affinity is definitely not dramatic 
and therefore it seems that the loss of one cation-π interaction only has a limited 
effect on binding. Comparable results were reported for NGAL when tested with 
enterobactin analogues, especially designed to disrupt one cation-π interaction 
(18). Therefore it can be inferred that binding to enterobactin is essentially 
analogous for Q83 and NGAL. 
 
4.1.2. Coulombic Interactions 
As suggested by the solution structure of the Q83/[GaIII(Ent)]3- complex and partly 
shown by the results above, cation-π interactions of the basic triad and π-π-
stacking with Trp62 play important roles in enterobactin binding. Still other 
electrostatic forces, particularly coulombic interactions, might also contribute 
significantly. 
Higher ionic strength of the buffer might weaken coulombic interactions to the 
ligand in the calyx dramatically compared to its effect on cation-π interactions. 
Hence, determining the KDs at different salt concentrations should reveal the 
predominant electrostatic forces for siderophore binding. The KDs for both, NGAL 
and Q83 for [FeIII(Ent)]3- were measured at different NaCl-concentrations by 
fluorescence quenching (Fig. 20). 
A decrease in affinity from 0.76 nM at 50 mM NaCl to 2.2 nM at 2 M could be 
observed. This decrease with ionic strength is not dramatic and so coulombic 
interactions are not considered to be the major forces for the complex formation. 
Similar conclusions can be drawn from the results for NGAL (Fig. 33). The KD values 
also showed the tendency to increase with higher salt concentrations. The reported 
KD of 0.41 nM at low salt concentration (7) increased to 1 nM at 1 M NaCl and 2.8 
nM at 2 M NaCl.  
 
  
57 
-20 0 20 40 60 80 100 120 140 160 180 200 220 240
30
40
50
60
70
80
90
100
110 Q83
I
[FeIII(Ent)]3- / [nM]
 1.0 M NaCl,        KD = 1.13 ± 0.17 nM
 1.5 M NaCl,        KD = 1.90 ± 0.25 nM
 2.0 M NaCl,        KD = 2.22 ± 0.41 nM
 
Fig. 32. Fluorescence quenching analysis of Q83 at different salt concentrations. 
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 1 M NaCl,       KD = 1.04 ± 0.14 nM
 2 M NaCl,       KD = 2.76 ± 0.83 nM
 
Fig. 33. Fluorescence quenching analysis of NGAL at different salt concentrations. 
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To confirm these results, the affinity for Q83 to a differently charged ligand was 
investigated. Therefore enterobactin was coordinated to vanadium instead of iron, 
resulting in an overall charge of the complex [VaIV(Ent)]2- of -2 instead of -3 for the 
iron-complex [FeIII(Ent)]3-. 
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Fig. 34. Fluorescence quenching of Q83 upon addition of [VaIV(Ent)]2-. 
 
The measured KD of 1.67 nM again did not reveal a great change in affinity, 
supporting the assumption that coulombic interactions are of limited importance 
for the Q83-Ent interaction.  A comparable result of 2.26 nM was reported for NGAL 
(32). 
 
Generally the results confirm a very similar binding mode for Q83 and NGAL 
towards siderophores. 
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4.2. Dynamics of NGAL 
 
4.2.1. 1H-15N HSQC Peak Assignment 
The HSQCs of the ligand-free and Ent-bound form of NGAL were assigned by HNCA, 
HNCO and HN(CA)CO. The HSQC of ligand-free NGAL, which is available on the PDB, 
was used as a template. The following residues could not be assigned for the free 
form: V32, M49, Y50, S66, V67, L71, I78, L122, I170, D171 and I174. 
In the bound form several peaks were considerably shifted and therefore 
assignment was more ambiguous. The following amino acids could not be assigned: 
S3, V32, A35, N37, D43, V67, L68, F81, V82, L122, F131, Q145, G158, V168 and 
I174. 
 
Fig. 35. Overlaid 1H-15N HSQC spectra of free (blue) and Ent-bound (red) NGAL. In the structure on the right, 
peaks that are significantly shifted in the HSQC are highlighted in red. 
 
4.2.2. CPMG 
For free NGAL the CPMG experiment revealed pronounced backbone dynamics in 
the β-barrel and in various loop regions. The dispersion plots of the residues Q17, 
K28, V31, E42, D45, L68, F69, R70, C74, D75, W77, T80, F81, V82, F90, G93, T102, 
M118, Q126, K132, T134, L135, E141, L142, T143, E148, H163, D171, Q172 and 
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D175 show significant exchange in the intermediate exchange regime. Intermediate 
exchange means that the chemical shift difference between the conformations and 
the exchange rate are of similar magnitude. 
Dynamics is almost entirely quenched upon Ent binding. Only slight intermediate 
exchange was observed in the dispersion plots of the residues Q26, G33, K60, S61, 
G93 and S103.  
Fig. 36 shows the dispersion plots of residue T134, which is located in the β-barrel, 
for the free and Ent-bound NGAL. The absence of dynamics in the bound form is 
clearly visible. It should be noted that R20, the value R2,eff is approximating at 
infinite νCPMG, is bigger for the free form. This indicates additional exchange that is 
not refocused by the П pulses. 
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Fig. 36. Dispersion plots for Thr134 of the free and Ent-bound NGAL. Exchange is revealed for the free but 
not for the Ent-bound form. The CPMG was measured at an 800 MHz and 600 MHz spectrometer. 
 
Fig. 37 shows the dispersion plots for residue S103, which revealed most significant 
exchange in the Ent-bound protein. Dynamics is much less pronounced than for 
T134 in the free form as can be seen by the lower ΔR2,eff. Again the plots reveal 
additional exchange in the free form, indicated by the higher R20 values. 
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Fig. 37. Dispersion plots for Ser103 of the free and Ent-bound NGAL. Slight exchange is revealed for the 
bound form. The free form displays a higher R2
0 value indicating additional exchange that is not refocused by 
the П pulses. 
 
In Fig. 38 residues that showed exchange in the free form are highlighted in the 
left and those that revealed slight exchange in the bound form are highlighted in 
the right structure. The two residues for which the dispersion plots are displayed 
above are marked in a different color. 
 
      
 
Fig. 38. Structure of NGAL with residues that revealed exchange in the free (left) and Ent-bound (right) 
form highlighted. T134 is marked in blue (left) and S103 in green (right). 
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4.3. Mammalian Siderophores – Catechol Binding Mode of Q83 and 
NGAL 
 
As pointed out in the introduction, NGAL is not only capable of binding bacterial 
siderophores in its calyx but most likely also plays a role in iron transport mediated 
by mammalian siderophores. The compounds found so far are structurally tightly 
related to enterobactin. Catechol basically is the iron-binding moiety of 
enterobactin and is derived in mammalian as well as in bacterial metabolism as a 
dietary compound. Recent studies revealed its ability in NGAL-mediated iron 
transport and the supposable link to NGAL’s partly high expression levels in aseptic 
diseases (4). 
The catechol derivative 2,5-dihydroxybenzoic acid was shown to be the iron-
binding component of the mammalian siderophore associated to the murine 
homologue of NGAL, 24p3 (5). In contrast, the iron binding moiety of enterobactin 
is 2,3-dihydroxybenzoic acid. 
In order to gain further insight into the binding mode of these compounds to NGAL, 
the interactions were monitored by fluorescence and NMR titrations. The results 
might also be informative for iron delivery mechanisms of NGAL. 
 
     
Fig. 39. Structures of catechol (left), 2,3-Dihydroxybenzoic acid (middle) and enterobactin (right). 
 
The measurements were done at pH 7.4, as especially for catechol the affinity 
significantly decreases below pH 7 (4). 
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4.3.1. Fluorescence Quenching 
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Fig. 40. Fluorescence quenching of NGAL upon addition of Cat and Cat-FeIII. The concentration on the x-axis 
is plotted for three Cat moieties to allow better comparison with Ent. The observable “shoulder” in the 
titration curve and the fact that it cannot be fit with the single binding site model suggests sequential binding. 
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Fig. 41. Fluorescence quenching of NGAL upon addition of 2,3-DHBA and 2,3-DHBA-FeIII. The curve cannot 
be fit with the single binding site model. The presence of iron increases affinity more extensively than is the 
case for Cat. 
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The fluorescence quenching plots for catechol display a “shoulder”, which makes it 
impossible to extract KD values with a single binding site model. The results 
indicate the successive binding of the ligand to the distinct binding pockets in the 
calyx. In the presence of one equivalent iron and at pH 7 the predominant form of 
catechol is supposed to be Fe(Cat)2 (4). Therefore it is suggested that in the 
beginning of the titration primarily Fe(Cat)2 is occupying two binding pockets, 
corresponding to the first distinct decay in the plot. 
The plots for 2,3-DHBA also cannot be fit with a single binding site model. A 
sequential binding mode can be inferred, although it is not as explicitly visible than 
for catechol. The presence of iron is more important for binding of 2,3-DHBA than 
catechol. 
 
Basically similar behavior upon addition of catechol and 2,3-DHBA was observed for 
Q83. The plots are not shown as they only provide qualitative information and are 
therefore redundant with respect to the plots for NGAL. 
 
 
4.3.2. 1H-15N HSQC Titrations 
In order to gain further information on the binding mechanism, HSQC titrations 
with Cat-GaIII and 2,3-DHBA-GaIII for NGAL and Q83 were carried out. The 
information that can be obtained from the spectra is essentially similar for both 
proteins. Therefore again only plots for NGAL are shown. 
 
Fig. 42 shows an overlay of spectra of NGAL without ligand, at 1 equivalent (eq) 
Cat-GaIII and saturated with Cat-GaIII (5 eq). After addition of 1 eq, several peaks of 
the free form are vanished and occur at different chemical shifts. Upon saturation 
with ligand, another subset of peaks appears, whereas the first subset vanishes. 
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Fig. 42. HSQC titration of NGAL with Cat-GaIII. Red – free form, orange – 1 eq Cat, blue – 5 eq Cat. The framed 
section is shown in the close-up below. 
 
 
Fig. 43. Close-up of the peak shifts of Gly93, Thr91 and Tyr62 upon titration with Cat-GaIII. 
Gly 93 
Thr 91 
Tyr 62 
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The close-up in Fig. 43 displays the peaks of Gly93, Thr91 and Tyr62 that appear at 
distinct chemical shifts in the free form and show similar chemical shifts at 
saturation with catechol. For Thr91 it is clearly visible that the peak at 1 eq is not 
directly located in between the peaks for the free and saturated protein. This 
means that there are more than the two forms, free and saturated, present at that 
ligand concentration and thus confirms the sequential binding mode. There are 
several possible states of the binding site present at intermediate ligand 
concentrations (e.g. 1 eq) with distinctly occupied binding pockets. 
 
 
 
Fig. 44. Exchange between different loading states. The scheme represents the three binding pockets in the 
calyx of NGAL, loaded with a different number of catechol moieties (A, B, and C). The state of only one binding 
pocket occupied is not shown. Furthermore more states are possible if the three binding pockets are 
distinguished. Participation of GaIII is also not included in that scheme. 
 
The fact that only one subset of peaks is observable in the spectrum at 1 eq 
catechol suggests fast exchange between different loading states in the calyx. 
Considering for instance exchange between state A and B this means that kAB + kBA 
>> ΔωAB. The peak appears at the average of the chemical shifts of exchanging 
states weighted with their populations, ω = pA*ωA + pB*ωB + pC*ωC. 
 
In Fig. 45 the NGAL spectrum at saturation with Ent is compared to the spectrum at 
saturating conditions of catechol. The spectra are almost identical which suggests a 
similar binding mode. Residues corresponding to the peaks that are shifted are 
highlighted in the protein structure below. 
 
kAB 
kBA 
kBC 
kCB 
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Fig. 45. HSQC spectra of NGAL saturated with Ent-GaIII and Cat-GaIII. Red – Ent-bound, blue – Cat-bound. 
 
 
Fig. 46. Structure of NGAL complexed with apo enterobactin. Residues that show significantly different 
chemical shifts in Fig. 45 are highlighted in red. 
 
The spectra for the titrations with 2,3-DHBA-GaIII are shown below. The same 
conclusions than for binding of catechol can be drawn for 2,3-DHBA. 
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Fig. 47. HSQC titration of NGAL with 2,3-DHBA-GaIII. Red – free form, blue - 1 eq DHBA, orange – 5 eq DHBA. 
The framed section is shown in the close-up below. 
 
 
Fig. 48. Close-up of the peak shifts of Gly93, Thr91 and Tyr62 upon titration with 2,3-DHBA-GaIII. 
Thr 91 
Gly 93 
Tyr 62 
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4.3.3. X-Ray Crystallography 
X-ray crystallography was done in order to gain further insight into the orientation 
of ligands inside the calyx of NGAL. After doing a small scale crystallization screen, 
effective conditions were found to obtain crystals of NGAL usable for x-ray 
diffraction. Best yield was obtained at crystallization conditions of 1.2 M 
ammonium sulphate, 0.1 M sodium acetate and 93 mM NaCl at pH 4. 2,3-DHBA was 
tried to be bound to the calyx by co-crystallization and soaking of the crystals that 
were grown in ligand-free conditions. However, for all trials the electron density 
map revealed the sulfate-ion in the calyx but no ligand. Apparently the calyx is 
easily accessible for small, soluble molecules. The results of x-ray crystallography 
could not be employed for investigation of ligand binding. 
 
 
Fig. 49. Crystals of NGAL in a hanging drop. Crystallisation conditions 
in the drop were 1.2 M AS, 0.1 M NaAc and 93 mM NaCl at pH 4. 
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4.4. Fatty Acid Binding Mode of Q83 
 
4.4.1. Delineating Significant Residues 
The binding site for fatty acids is located towards the closed end of the calyx. In 
consideration of the solution structure (Q83/AA) binding seems to be mainly 
stabilized by hydrophobic contacts between aromatic residues of the protein (Tyr51 
and Tyr76) and the aliphatic chain of AA. Tyr92 seems to be important for hydrogen 
bonding to the polar head of the fatty acid. Also the side chains of Thr90 and Arg6 
are located near the AA carboxylate. The mutants R6A, R6Q, Y51F, Y76F, T90A and 
Y92F were tested for their affinities to AA. 
 
 
 
Fig. 50. Structure of Q83 with mutated residues marked in red. 
Arachidonic acid is shown in stick representation. 
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Fig. 51. DAUDA titration of the mutant T90A, monitored by fluorescence 
analysis. The KD for DAUDA was determined for every mutant. The saturated 
protein was subsequently titrated with AA. 
 
 
Most significant reduction in affinity was observed for deprivation of the hydroxyl 
group of Tyr92 or Thr90, respectively. The Y92F mutant showed a KD of 1864 nM, 
compared to 26 nM for the wild type. A dissociation constant of 1078 nM was 
revealed for the mutant T90A. The hydroxyl groups of Tyr76 and Tyr51 seem to be 
less crucial. A KD of 174 nM for Y76F and 108 nM for Y51F was measured. Mutation 
of Arg6 into glutamine slightly reduced the affinity to 42 nM. A stronger effect was 
shown for mutation of the same residue to alanine, resulting in a KD of 120 nM. 
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Fig. 52. AA titration of the mutant T90A after saturation with DAUDA. X0 gives 
ln([AA]) at the inflection point. Its exponential reveals the AA concentration at 
which DAUDA and AA are bound to the protein in equal amounts.  
 
 
                      Q83 mutant Ligand  KD / [nM]  
                           R6A DAUDA  115 
                                                           AA   42   
                           R6Q DAUDA  120  
                                                           AA   98   
                           Y51F DAUDA  296 
                                                           AA   108   
                           Y76F DAUDA  160 
                                                           AA   174   
                           T90A DAUDA  1388  
                                                           AA   1078   
                           Y92F DAUDA  265  
                                                           AA   1864   
 
Table 3. Affinities of different Q83 mutants for DAUDA and AA. 
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Fig. 53. Positions of the mutated residues with respect to bound arachidonic acid. The orientation of the 
close-ups is different to the protein structure above. 
 
 
4.4.2. Chain Length Dependence 
Various fatty acids with different chain length and number of double bonds were 
investigated upon binding to Q83 by fluorescence quenching. 
Tyr51 
Tyr76 
Arg6 
Tyr92 
Thr90 
A 
B 
C 
A 
B 
C 
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Fig. 54. Arachidonic acid (AA). The configuration of all four double bonds is cis. The actual structure is not 
linear but bent around C-10. 
 
 
Fig. 55. Linoleic acid (LA). The actual structure is curved due to the rigid cis double bonds. 
 
 
Fig. 56. Oleic acid (OA). The real structure reveals a kink due to the cis bond. 
 
 
Fig. 57. Palmitic acid (PA). 
 
 
Fig. 58. Myristic acid (MA). 
 
 
Fig. 59. Lauric acid (LAUA). 
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Fig. 60. Replacement of DAUDA bound to Q83 upon addition of fatty acid. Fluorescence intensity is plotted 
against the natural logarithm of fatty acid concentration. The inflection points are revealed by a sigmoidal fit. 
 
The affinity for fatty acids decreased quite linearly with chain length. The KD of 26 
nM for arachidonic acid (C20:4 all-cis-5,8,11,14) approximately doubled to 40 nM 
for linoleic (C18:2 cis,cis-9,12) and oleic acid (C18:1 cis-9). Reduction of double 
bonds doesn’t seem to affect the affinity. For the other tested fatty acids affinity 
further decreased with reduction of chain length from 77 nM for palmitic acid 
(C16:0) to 100 nM for myristic acid (C14:0) and 200 nM for lauric acid (C12:0). 
 
          Ligand     KD / [nM]     
          DAUDA 104  
          AA 26  
          OA 44  
          LA 43  
          PA 77  
          MA 103  
          LAUA 200    
 
Table 4. Dissociation constants of Q83 for different fatty acids. 
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If the KD values are plotted against the number of C-atoms of the corresponding 
fatty acids, the curve can be fit with a first order exponential decay. 
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Fig. 61. Dissociation constants plotted against the number of carbons of the corresponding fatty acids. 
 
Considering that K = -e-ΔG/RT, the exponential decay indicates that, beginning from 
lauric acid (C12), every additional CH2 group reduces the ΔG by a constant factor. 
Rewriting the equation gives ΔG = -RT lnK. The calculated ΔG values for the 
different fatty acids and the corresponding ΔΔG per CH2 group are given in the 
following table. Except for the outlier of palmitic acid the results indeed show a 
relatively constant contribution of every additional CH2 group to the binding 
affinity. The conclusion is that increasing affinity with chain length can be 
attributed to the hydrophobic effect. The nonpolar fatty acid chain minimizes the 
contact with the solvent by burying inside the protein, thereby increasing the 
entropy of the solvent. The longer the hydrocarbon chain, the higher is the gain of 
entropy and therefore the absolute value of ΔG. It should be noted that ΔG values 
are given for the dissociation reaction, which means that a positive ΔG favours the 
protein-ligand complex. 
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Fatty acid  Lipid numbers     ΔG/[J/mol]  ΔΔG/[J/mol] per CH2 
    LAUA        C12:0      37837   
    MA         C14:0      39465   814 
    PA         C16:0      40179   357 
    LA         C18:2      41608   715 
    OA         C18:1      41552   686 
    AA         C20:4      42842   617   
Table 5. Calculated ΔG values for binding of the different fatty acids and contributions per CH2 group. 
 
4.5. Dual Ligand Binding Mode of Q83 
 
The solution structure of the Q83-Ent-AA-complex and HSQC peak shifts revealed 
that the protein can bind both ligands simultaneously (46). By fluorescence 
quenching analysis it should be investigated how the binding of one ligand affects 
the affinity for the second ligand at the other binding site of Q83. Possible 
allosteric mechanisms upon binding of specific unsaturated fatty acids or 
enterobactin binding should be revealed. 
 
     Q83           Q83/AA  
 
 
     Q83/[FeIII(Ent)]3-             Q83/[FeIII(Ent)]3-/AA 
 
Fig. 62. Schematic representation of the dual binding mode of Q83. The KD superscript denotes the ligand 
which is binding. The subscript in brackets indicates the corresponding Q83 form. 
KDAA 
 KDEnt(AA) 
KDAA(Ent) 
KDEnt 
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4.5.1. Affinity for Ent to AA-bound Form  
The KD for enterobactin in the presence of bound arachidonic acid (KDEnt(AA)) could 
be determined directly by ordinary tryptophan fluorescence quenching. 
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I
[FeIII(Ent)]3- / [nM]
Q83 - 2 µM AA
 
Fig. 63. Fluorescence quenching upon addition of Ent at saturating AA concentration. 
 
A slight decrease in affinity of Q83 for [FeIII(Ent)]3- in the AA-bound form (KDEnt(AA) = 
1.33 nM) was observed, compared to the free form (KDEnt = 0.54 nM). The raise in KD 
is not dramatic but indicates that the change in the potential energy surface upon 
AA binding is transmitted to the Ent binding site. 
 
4.5.2. Affinity for AA to Ent-bound Form 
The affinity for arachidonic acid when enterobactin is bound (KDEnt(AA)) is more 
complicated to investigate, as the enterobactin bound in the calyx quenches 
DAUDA fluorescence. Hence, only the binding of the fatty acid to the Ent-free 
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Q83 can be monitored directly. However, in the presence of both, Ent-free and 
Ent-bound Q83, conclusions can be drawn on the affinity to Ent-bound protein by 
measuring DAUDA fluorescence quenching. 
Some approximations have to be made for those calculations and therefore the 
obtained dissociation constants should rather be considered as qualitative bench 
marks than exact quantitative values. 
 
First an apparent dissociation constant (KD(app)) of AA and DAUDA-bound Q83 is 
determined. For this purpose a fluorescence quenching experiment is consulted, 
where DAUDA was applied at saturating concentration (5 µM DAUDA and 2 µM Q83) 
and the mixture was titrated with AA. This is exactly the experiment that was 
carried out for measuring the KD of AA and Q83 but this time the KD for the 
following dissociation reaction is calculated. 
 
    [Q83/AA] + [DAUDAfree]      [Q83/DAUDA] + [AAfree] 
 
This is a coupled equilibrium between two dissociation reactions but for 
determining the KD(app) it is treated as if [DAUDAfree] would be constant. KD(app) can 
be expressed in the following way. 
 
KD(app) = [AAfree] * [Q83/DAUDA] / [Q83/AA] 
 
KD(app) is obtained by fitting the titration curve the same way as done for direct 
quenching in the calyx (Fig. 63). 
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Fig. 64. Fluorescence decrease due to DAUDA replacement by AA in the Q83 secondary 
binding site. The curve is fit by the one-ligand equation which provides an apparent KD, KD(app). 
 
In other experiments, Ent-bound and Ent-free Q83 was provided in the cuvette in 
certain ratios, whereas Ent was assumed to be all bound to the protein. The 
following setups were tried. 
 
[Q83free] / [Q83Ent] 
 
3 µM Q83 
1 µM [FeIII(Ent)]3- 
5 µM DAUDA 
 
2 µM / 1 µM 
 
4 µM Q83 
2 µM [FeIII(Ent)]3- 
5 µM DAUDA 
 
2 µM / 2 µM 
 
 
6 µM Q83 
4 µM [FeIII(Ent)]3- 
5 µM DAUDA 
 
2 µM / 4 µM 
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The calculation is shown for a [Q83free] / [Q83Ent] ratio of 2 µM / 2 µM. Fluorescence 
decrease was monitored as usual upon addition of AA and plotted against ln[AA]. 
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Fig. 65. Fluorescence decrease upon addition of AA. Only the DAUDA replacement in the Ent-free Q83 is 
monitored as the fluorescence of DAUDA bound to Ent-bound Q83 is quenched. The calculation explained in the 
text was done at 1.6 µM AA, indicated by the blue lines, corresponding to 41% of total intensity decline. 
 
The minimal intensity at complete saturation with AA is determined. The ratio of 
Ent-free protein bound to AA ([Q83free/AA]) to total Ent-free protein ([Q83free]) can 
be calculated at a certain AA concentration by dividing the decrease of 
fluorescence intensity at that concentration through the total decrease in 
intensity. 
[Q83free/AA] / [Q83free] = ΔI / ΔIges 
 
In Fig. 64 this is shown schematically for [AA] = 1.6 µM or ln([AA]/[µM]) = 0.47, 
respectively. The following calculation is carried out at that AA concentration. 
ΔIges = 84,3 
ΔI = 34,6 
  
82 
[Q83free/AA] / [Q83free] = 0.41 
 
As the Ent-free Q83 concentration ([Q83free]) is known (2 µM), the Ent-free Q83 
concentration, which is bound to AA ([Q83free/AA]) can be calculated. 
 
[Q83free/AA] = 2 µM * 0.41 = 0.82 µM 
 
Assuming that all protein is either in DAUDA-bound or AA-bound form, the DAUDA-
bound protein concentration ([Q83/DAUDA]) is obtained. 
 
[Q83/DAUDA] = [Q83free] - [Q83free/AA] = 1.18 µM 
 
The values for [Q83/DAUDA] and [Q83free/AA] are then substituted into the 
equation for KD(app). Now the free AA concentration ([AAfree]) can be calculated. 
 
KD(app) = [AAfree] * [Q83/DAUDA] / [Q83/AA] => [AAfree] = 0.076 µM 
 
A second equation is expressed, describing the KD of Ent-bound Q83 for AA. 
 
KDEnt(AA) = [AAfree] * [Q83Entfree] / [Q83Ent/AA] 
 
KDEntAA … KD of Ent-bound Q83 for AA 
[AAfree] … concentration of free AA 
[Q83Entfree] … concentration of Ent-bound protein without AA bound 
[Q83Ent/AA] … concentration of Ent- and AA-bound protein 
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[AAfree] is already known. [Q83Ent/AA] is obtained by subtracting the AA 
concentration that is bound to Ent-free Q83 and the free AA concentration from 
the total AA concentration at the investigated titration point. 
 
[Q83Ent/AA] = [AA] - [Q83free/AA] – [AAfree] = 0.704 µM 
 
Consequently [Q83Entfree] can be calculated as follows. 
 
[Q83Entfree] = [Q83Ent] - [Q83Ent/AA] = 1.296 µM 
 
Finally KDEntAA is obtained. 
 
KDEnt(AA) = [AAfree] * [Q83Entfree] / [Q83Ent/AA] = 0.139 µM = 139 nM 
 
With a second calculation at the point of 3 µM [AA] a KDEnt of 123 nM was obtained. 
For the ratio 2 µM free / 1 µM Ent-bound Q83, a dissociation constant of 160 nM 
was determined. A lower affinity was obtained for the setup 2 µM free / 4 µM Ent-
bound Q83 with a KD of 247 nM. 
 
In summary the measurements revealed a decrease of AA affinity by a factor of five 
to ten for Ent-bound Q83 compared to free protein. Thus the effect of bound Ent 
on AA binding is bigger than for the reverse case. 
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Fig. 66. Dual binding mode of Q83. The scheme is analogous to Fig. 62. Binding of one ligand reduces the 
affinity for the other ligand in the second binding site. Bound enterobactin seems to have a significant effect 
on the affinity for arachidonic acid, whereas minor influence was found for the reverse case. 
 
 
 
 
 
 
 
KDfree(AA) = 26 nM 
KDAA(Ent) = 1.3 nM 
KDEnt(AA) ≈ 150 nM 
KDfree(Ent) = 0.5 nM 
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5. DISCUSSION 
 
5.1. Siderophore Binding 
 
 
So far NGAL has been the only eukaryotic protein shown to bind siderophores. The 
data provided here completes evidence for Q83 to be a member of the siderocalin 
family. In fact it binds siderophores with a very similar binding mode and affinity to 
NGAL, in spite of a substantially different calyx construction. 
Structural features for the Ent-siderocalin interaction could be characterized by 
mutant studies, complementing the picture from the already available 
Ent/Q83[GaIII(Ent)]3- solution structure. Residues essential for interaction are Trp62, 
Lys83 and Arg113, analogous to Trp79, Lys125 and Lys134 in NGAL. This set of 
structurally conserved residues seems to be representative for the siderocalin 
protein family. 
Evidence that Q83 and NGAL are homologs is completed by the fact that both 
proteins are involved in the same biological processes, e.g. immune response (8, 
37), inflammation (13), tissue differentiation (10) and cancer progression (14). The 
roles of NGAL and Q83 in innate immune response and iron delivery pathways can 
directly be attributed to their abilities to bind siderophores. Other functions are 
most likely also intimately connected to the ligand binding properties of the 
proteins but eventually related to a secondary binding site. 
 
5.2. Fatty Acid Binding 
 
A very exceptional feature of Q83 is the existence of two distinct binding sites (46). 
Even if biological mechanisms are not yet understood, the fatty acid binding site 
might play a key role for deciphering the various functions of the protein. AA, 
which showed the highest affinity among the tested fatty acids, is a key 
inflammatory intermediate and acts in regulation of several signalling enzymes. 
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Fatty acid binding to NGAL could not be demonstrated so far but still it seems to be 
evident that the human protein also comprises the secondary binding site. Besides 
analogous functions, NGAL exhibits a very similar structure to Q83. Residues which 
were shown to be crucial for binding in Q83 are present at comparable regions in 
NGAL. Thr90 and Tyr92 of Q83, which turned out to be of major importance, might 
have their analogues in Thr114 and Tyr116 in the human protein. 
A possible reason why binding could not be observed might be that fatty acids, in 
contrast to siderophores, possibly access their binding site via the narrower end of 
the β-barrel. In this region an N-terminal extension of the amino acid sequence is 
found in NGAL, which is not present in Q83. This loop sequence is responsible for 
the 310-helix to be located directly in front of the opening at that end of the 
protein and consequently fatty acid binding might be prevented in NGAL (Fig. 67). 
Modification of the helix in vivo, e.g. proteolytic cleavage would then be necessary 
to make the secondary binding site accessible. 
 
      
 
Fig. 67. Bottom view of Q83 (left) and NGAL (right). The 310-helix in NGAL inhibits access to the interior of 
the protein. 
 
In an attempt to demonstrate ligand binding in the fatty acid binding site, a mutant 
of NGAL that lacks the N-terminal extension was cloned but could not be expressed 
successfully. 
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From studies on Q83 it can be inferred that binding of Ent is not beneficial for the 
affinity to AA. The Ent bound protein revealed an approximately six times higher 
dissociation constant for AA than the free form of Q83. This reduction in affinity is 
possibly due to a decrease in protein dynamics upon ligand binding. The CPMG for 
NGAL revealed that pronounced dynamics in the free form of the protein is almost 
entirely quenched in the Ent-bound protein. 
 
5.3. Outlook 
 
Further research for Q83 could include a more detailed investigation of its dual 
binding mode in consideration of possible allosteric mechanisms. As two binding 
sites are present in a single protein, biologically relevant correlation is suggested, 
however, could not be demonstrated so far. Saturation with AA reduced the affinity 
for Ent by a factor of two. Other fatty acid ligands could be tried for a possibly 
more significant effect on Ent-binding. For the reverse case, probing affinities for 
fatty acids in the presence of bound Ent, a more effective method would have to 
be established, providing reliable dissociation constants for various fatty acids. 
If the findings of Q83 could be applied on its human homologue NGAL, this would 
be a major step towards elucidation of its pleiotropic functions. 
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7. APPENDICES 
 
Zusammenfassung 
 
NGAL ist ein 178 Aminosäuren großes, menschliches Protein und gehört zur Familie 
der Siderocaline. Es kommt in sekretorischen Vesikeln von Granulozyten vor. 
Siderocaline sind eine Unterklasse der Lipocaline. Charakteristisch für diese 
Proteinfamilie sind zum Einen die Struktur eines acht-strängigen, antiparallelen Β -
Fasses und zum Anderen die Bindung von kleinen, hydrophoben Liganden. 
Siderocaline im Speziellen binden als Liganden sogenannte Siderophore, eisen-
komplexierende Moleküle. Siderophore werden beispielsweise von Bakterien 
ausgeschieden, um Eisen ihres Wirtes zu komplexieren und daraufhin wieder in die 
Zelle transportiert zu werden. Eisen wirkt auf Grund seiner geringen 
Bioverfügbarkeit oft als limitierender Faktor bakteriellen Wachstums. Siderocaline 
können in diesem Zusammenhang als Mechanismus des Wirtsorganismus verstanden 
werden, um dieser Eisendepletion entgegen zu wirken. NGAL spielt neben der eben 
beschriebenen Funktion bei bakteriellen Infektionen aber eine Rolle bei einer 
Vielzahl anderer Prozesse, wie z. B. Entzündungen, Eisentransport, 
Gewebsdifferenzierung und Krebsentwicklung. Es scheint sehr wahrscheinlich, dass 
diese Funktionen direkt mit den Ligandenbindungseigenschaften zusammenhängen. 
Q83 ist das Wachtel-Homologe von NGAL und ist als solches in der Forschung 
wesentlich weniger behandelt. Trotz sehr geringer Sequenzidentität mit NGAL 
weist es vergleichbare Funktionen und sehr ähnliche Struktureigenschaften auf. Die 
bei Q83 kürzlich entdeckte, zweite Bindungsstelle für Fettsäuren (46), könnte sich 
als wesentlicher Faktor zur Aufklärung seiner pleiotropen Funktionen erweisen. 
In der vorliegenden Diplomarbeit wurden die Bindungseigeinschaften von NGAL und 
Q83 zu verschiedenen Liganden untersucht. Fluoreszenzquenching Experimente und 
makromolekulare NMR Spektroskopie an bestimmten Mutanten von Q83 lieferten 
detaillierte Informationen des Siderophor-Bindungsmechansimus. Außerdem konnte 
die Fettsäure-Bindungsstelle von Q83 charakterisiert werden. Ein Einblick in die 
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Dynamik von freiem NGAL und des Protein-Ligand-Komplexes, mit dem Siderophor 
Enterobactin gebunden, wurde ebenfalls mittels NMR spektroskopischer 
Untersuchungen gegeben. 
 
Abstract 
 
NGAL is a 178 amino acids human protein, belonging to the siderocalin family. It is 
found in secretory vesicles of granulocytes. Siderocalins are a subclass of lipocalins. 
This protein family is characterized structurally by the formation of an eight-
stranded, antiparallel β-barrel and functionally by binding small, hydrophobic 
ligands. The ligands of siderocalins are so called siderophores, iron-chelating 
molecules. Siderophores are for instance excreted by bacteria, in order to capture 
iron from its host and transport it into the cell. Due to its low bioavailability, iron 
often accounts as limiting factor for bacterial growth. In this context siderocalins 
can be seen as the host’s mechanism to counteract iron-depletion. Besides this 
function in bacterial infection, NGAL plays a role in various other processes, e.g. 
inflammation, iron delivery, tissue differentiation and cancer progression. These 
functions are most likely intimately connected to the ligand binding properties. 
Q83 is the quail homologue of NGAL and is essentially less examined. In spite of low 
sequence identity with NGAL, it shows very similar functions and an analog 
structural fold. Q83’s newfound secondary binding site for fatty acids (46) might be 
a key feature for deciphering its pleiotropic functions. 
In this thesis the binding properties of NGAL and Q83 to different ligands were 
investigated. Fluorescence quenching experiments and macromolecular NMR 
spectroscopy on various Q83 mutants provided detailed information on the 
siderophore binding mechanism. Furthermore the fatty acid binding site of Q83 was 
characterized. An insight into the dynamics of free NGAL and the protein-ligand 
complex, with the bound siderophore enterobactin, was given using NMR 
spectroscopic methods. 
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